Ryan Allway October 2nd, 2020 Psychedelics Mind Cure Health Inc. (CSE: MCUR) (“Mind Cure” or the “Corporation”) is pleased today to announce the addition of Dr. Dan... Dr. Dan Engle Joins Mind Cure’s Advisory Board

Ryan Allway

October 2nd, 2020

Psychedelics


Mind Cure Health Inc. (CSE: MCUR) (“Mind Cure” or the “Corporation”) is pleased today to announce the addition of Dr. Dan Engle to the company’s scientific advisory board. Dr. Dan Engle is a world-renowned physician in both psychiatry and neurology and sits at the forefront of psychedelic research and peak performance training. His current practice combines functional medicine with integrative psychiatry to enhance the foundations of regenerative health, and he serves as the Medical Director at the Kuya Institute for Transformational Medicine.

In his role as scientific advisor, Dr. Dan Engle will contribute towards Mind Cure’s work in the realm of psychedelic research, treatment and integration. “I am thrilled to be joining Mind Cure on its mission to stimulate the evolution of how mental health is addressed,” said Dr. Dan Engle. “Through transformational medicine, technology and therapy solutions, there is a better path forward. I look forward to building it together with Mind Cure’s scientific advisory board and management team. This is an exciting time to co-create this new medical movement.”

Dr. Dan Engle will contribute significantly across Mind Cure’s strategic focuses of product research and discovery, technology integration, and clinical research. He has deep insights into product candidates through his time spent at the grassroots level within healing communities and his patient practice. He also possesses industry-leading experience with the applicability of technology and how it can be of service to the advancement of psychedelic work, from research through integration.

Philip Tapley, Chairman, President, and CEO stated, “We are going to benefit greatly from Dr. Dan Engle’s experience and expertise in treating mental health. He fundamentally understands both business and science and could have chosen to work with anybody in this space. The fact he is joining Mind Cure’s advisory board validates our focus on building our scientific team and operations the right way.”

“Bringing Dr. Dan Engle into Mind Cure is not only an honour, but a pivotal moment for us as we build our team with highly-regarded, deeply experienced and cutting-edge leaders in the psychedelic renaissance that will, as a part of the Mind Cure team, drive the revolution in mental health care,” said Kelsey Ramsden, Mind Cure’s COO. “We can’t wait to show what his brilliance and experience will do with the opportunities at hand.”

Mind Cure believes that the mental health space is ready for transformation, and that innovation and investment will lead to a major disruption in how mental health is treated. Mind Cure intends to further its investigation into new product candidates and treatments which are effective in treating mental health. These new product candidates range from nootropics, psychoactive products, and psychedelic substances.

About Dr. Dan Engle

Dr. Dan Engle is world-renowned for his specializations in psychiatry and neurology. With a background in integrative psychiatry, neurocognitive restoration, peak performance medicine and psychedelic research, Dr. Dan Engle helps individuals shift from illness and trauma to health and happiness. His trans-disciplinary approach focuses on healing the body and brain, the heart and mind and, finally, integrates the spirit to help individuals optimize all aspects of health for sustained fulfillment.

He received his medical degree from the University of Texas in San Antonio, his psychiatry residency degree from the University of Colorado in Denver and his Child and Adolescent Psychiatry Fellowship degree from Oregon Health and Sciences University. Dan also holds several Medical Directorships, is the Medical Director of Kuya Institute for Transformational Medicine and is the former Medical Director of several of Sedona, Arizona’s premier healing centers.

His programs include Freedom From Meds, a comprehensive and integrative tool kit for successful transition from psychiatric medications, the Concussion Repair Manual, facilitating the return to optimal function after concussion and traumatic brain injury, BOLD – Brain Optimization and Lifestyle Design – a coaching program for maximizing brain health and cognitive performance, and Full Spectrum Medicine, a research, education and advocacy platform pioneering the future psychiatric healing centers using consciousness expansion tools for root-cause healing and total life transformation.

About Mind Cure Health Inc.

Mind Cure is a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health. It is the therapeutic potential of nootropics, psychoactive products, and psychedelic substances to treat the profound distress of a world suffering from a mental health crisis that led to the formation of Mind Cure.

On Behalf of the Board of Directors
Philip Tapley, Chairman, President, and CEO
Phone: 1-888-593-8995

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )